Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Stephen M. Setter"'
Autor:
Celestina Barbosa-Leiker, Sterling McPherson, Brad P. Dieter, Robert Short, Katherine R. Tuttle, Kenn B. Daratha, Stephen M. Setter, Joshua J. Neumiller, Radica Z. Alicic, Brian J. Gates, Naomi Chaytor, Cynthia L. Corbett
Publikováno v:
American Journal of Nephrology. 44:122-129
Background: The hospital readmission rate in the population with chronic kidney disease (CKD) is high and strategies to reduce this risk are urgently needed. Methods: The CKD-Medication Intervention Trial (CKD-MIT; www.clinicaltrials.gov; NCTO1459770
Autor:
Sterling McPherson, Stephen M. Setter, Joshua J. Neumiller, Celestina Barbosa-Leiker, Katherine R. Tuttle, Radica Z. Alicic, Brad P. Dieter, Robert Short, Kenn B. Daratha, Naomi Chaytor, Brian J. Gates, Cynthia F. Corbett
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN. 13(2)
Background and objectives CKD is characterized by remarkably high hospitalization and readmission rates. Our study aim was to test a medication therapy management intervention to reduce subsequent acute care utilization. Design, setting, participants
Publikováno v:
Journal of Patient Safety. 10:186-191
To determine whether medication regimen complexity (MRC) could predict likelihood for occurrence of potential adverse drug events (ADEs), unplanned 30-day hospital readmission, or 30-day emergency department use in patients transitioning from hospita
Autor:
Stephen M. Setter, Gretchen I Riker
Publikováno v:
Home Healthcare Nurse. 30:474-485
Polypharmacy--the use of more medications than are clinically indicated--is a problem that affects many older adults. Adults aged 65 years and older make up approximately 13% of the population, but they consume nearly one third of all prescriptions d
Publikováno v:
Journal of the American Pharmacists Association. 52:492-497
Objective To explore associations between results of a rapid screening tool for cognitive impairment and individual patient characteristics in a sample of patients receiving outpatient anticoagulation therapy who were not previously diagnosed with a
Autor:
Joshua J. Neumiller, Stephen M. Setter
Publikováno v:
Clinical Therapeutics. 34:993-1005
Background Linagliptin is a dipeptidyl peptidase-4 inhibitor that was approved in 2011 by the US Food and Drug Administration as a treatment adjunctive to diet and exercise for the improvement of glycemic control in adults with type 2 diabetes mellit
Publikováno v:
Diabetes Spectrum. 24:234-238
Publikováno v:
Diabetes Spectrum. 24:171-177
Many pharmacological agents commonly used in clinical practice affect glucose homeostasis, interfering with the body's balance between insulin, glucagon, catecholamines, growth hormone, and cortisol. Drug-induced serum glucose alterations manifested
Autor:
Joshua J. Neumiller, Jonathan Dennis Carlson, Lindy D. Wood, Stephen M. Setter, Cynthia F. Corbett
Publikováno v:
American Journal of Health-System Pharmacy. 67:2059-2063
Managing the inpatient medications of patients with Parkinson’s disease (PD) poses many challenges to the pharmacist and other members of the health care team. Patients with PD, generally elderly, have different combinations of symptoms, are hospit
Publikováno v:
The American Journal of Geriatric Pharmacotherapy. 8:294-315
Background: Parkinson's disease (PD) is associated with a host of nonmotor symptoms, including psychosis, cognitive impairment, depression, sleep disturbance, swallowing disorders, gastrointestinal symptoms, and autonomic dysfunction. The nonmotor sy